Haemonetics stock holds steady near this week high with strong uptrend and overbought signals

Traders Union
All News
Companies
Haemonetics slips 0.01% to $78.70 today

Highlights

HAE sustained a 10.76% weekly surge, closing at $78.70 and confirming strong buyer momentum nearing resistance.
All major technical indicators signal overbought conditions, implying increased risk of consolidation or a reversal in the short term.
HAE is projected to trade between $77.27 and $79.17 next week, with a high probability of stabilization or further upside unless support breaks.

Uptrend confirmed as price holds above major moving averages

HAE is trading well above its MA-20 ($64.43), MA-50 ($60.72), and MA-200 ($63.05), confirming a strong uptrend across short-, medium-, and long-term frames. The Ichimoku Kijun on D1 sits at $66.00, below the current price, so it acts as immediate support. Near-term support is clustered at the MA-20 ($64.43), while key support comes from the MA-50 ($60.72). Near-term resistance is defined by the Ichimoku Kijun at $66.00 (acting as support due to its position), with the next key resistance appearing around the week’s high at $80.80.

Overbought momentum emerges as weekly gains approach resistance

Momentum remains robust, as the MACD on D1 signals a buy with a value of 5.63 and ADX also gives a buy signal at 22.61, reflecting positive trend strength. RSI (80.86), Stoch RSI (100.00), and CCI (171.73) all indicate overbought conditions, signaling caution for new entries. BBP on D1 shows strong buyer dominance, supported further by a positive Awesome Oscillator reading. HAE is trading at $78.70, up from its previous weekly close of $71.28, representing a 10.76% gain over the week. The price is at the very top of the weekly range (near resistance). Weekly volatility stands at 21.61%. The tone is dominated by a sharp recovery that has pushed the price to the upper boundary, although overbought signals warn of potential consolidation or reversal risk ahead.

Further upside likely as bullish signals outweigh downside risk

For the upcoming week, the projected price range is $77.27 to $79.17, keeping the price just below its 52-week high ($87.32) and well above the annual low ($47.32). Based on indicator signals (three out of four weekly signals in the Buy direction), there is a very high probability (more than 80%) of price stabilization or further upside, with a very low probability of a meaningful decline. Baseline scenario: HAE consolidates between $77.27 and $79.17 as the market digests recent gains. Bullish scenario: a sustained break above $80.80 could open the way to retest the yearly highs. Bearish scenario: if support at $77.27 fails, pullbacks could accelerate, but broader trend momentum still favors the bulls.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Earlier, analysts noted that Haemonetics was exhibiting strong bullish momentum, supported by positive technical trends and resilient market positioning. As current conditions evolve, traders should closely monitor for any shifts in momentum that could signal new opportunities or heightened risks in the near term.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.